In this Feb. 27, 2020, file photo, the DoorDash app is shown on a smartphone in New York. (AP Photo, File)
One of the largest delivery platforms in the U.S., DoorDash is getting into the growing prescription drug delivery business through a partnership with wholesale giant Sam's Club.
“Our partnership with DoorDash to launch this new service allows us to not only give our members more convenient healthcare options, but also delivers on our commitment to their overall wellness needs,” said John McDowell, vice president of pharmacy operations and divisional merchandise at Sam’s Club, in a statement.
DoorDash is tapping Drive, its white-label fulfillment platform for merchants, to power the partnership, which emerged specifically to meet shifting consumer expectations amid COVID.
“Businesses have evolved amidst the pandemic to prioritize the safety of their communities and to adapt to new consumer habits, and our goal is to help merchants meet those demands in a way that’s best for their business,” said Christopher Payne, chief operating officer at DoorDash.
The coronavirus pandemic has accelerated the adoption of prescription drug delivery services. Pharmacies in particular have turned to third parties to compete with online retailers.
For DoorDash, the partnership comes as the platform teams up with other companies outside of the food category, including PetSmart, Macy's, Walgreens, CVS Pharmacy, and 7-Eleven.
DoorDash will provide same-day delivery across Sam Club's 500 locations.
Sam's Club is offering free delivery on their first two pharmacy orders until the end of the year and then charging a flat fee of $7.99 per order.
Most members of the Federal Reserve’s interest-rate setting committee supported further reductions to its key interest rate this year, minutes from last month’s meeting showed.
Sinead O’Sullivan breaks down Taylor Swift’s genius marketing for The Life of a Showgirl, which just set the record for most albums sold in a single week.
Markets are emerging from a turbulent Q3. Horizon’s Mike Dickson shares insights on interest rates, small caps, and where investors should look in Q4 and beyond
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
Former Cisco Systems CEO John Chambers learned all about technology’s volatile highs and lows as a veteran of the internet’s early boom days during the late 1990s and the ensuing meltdown that followed the mania. And now he is seeing potential signs of the cycle repeating with another transformative technology in artificial intelligence. Chambers is trying take some of the lessons he learned while riding a wave that turned Cisco into the world's most valuable company in 2000 before a crash hammered its stock price and apply them as an investor in AI startups. He recently discussed AI's promise and perils during an interview with The Associated Press.
Grove Collaborative’s CEO shares how the company is reinventing everyday goods with sustainability at the core and working toward a plastic-free future.
Atlanta Mayor Andre Dickens shares plans for affordable housing, community-led growth, and why private and public grocery stores could be key to food equity.
